Sanofi executes first tranche of €5 billion stock buyback
Sanofi (NASDAQ:SNY) has executed the first tranche of its €5 billion stock buyback program. A first tranche of this program was announced on February 3, 2025, and executed on February 5, 2025, for an ...
DPA International on MSN21m
French pharma firm Sanofi to buyback up to €2 billion in shares
French pharmaceutical and healthcare company Sanofi on Friday announced a share buyback plan worth up to €2 billion ($2.08 ...
Epitopea Appoints Klaus Edvardsen M.D., Ph.D. as Chief Medical Officer
Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, ...
pharmaphorum16m
How do HCPs view the potential of AI in the pharmaceutical industry?
The integration of AI in healthcare as a means by which to enhance diagnostic accuracy and treatment planning also appeared ...
L'Oreal shares drop after China drags down quarterly sales
Shares in French cosmetics giant L'Oreal fell by more than 4% in early trade on Friday after the company posted its slowest ...
Digestive Health Products Market Poised For Significant Growth, Expected To Reach USD 94.4 Billion By 2032
Global Digestive Health Products Market was valued at USD 47.8 billion in 2023. It is projected to reach approximately USD 94.4 billion by 2032 The Dairy Products Segment Held The Highest Revenue ...